OSF Ventures
VC Fund
Peoria, United States
OSF Ventures is a VC fund in Peoria focused on Health Care and Medical Device. OSF Ventures invests financially and operationally in opportunities that will improve patient outcomes, enhance patient experience and reduce the cost of health care. They believe in not only investing financially, but also strategically through comprehensive collaboration.OSF Ventures employs the principles of humble curiosity and consideredrisk to create conditions conducive to exploring new thinking, challenging conventions and championing better, more compassionate care for all.OSF Ventures is a member of the OSF HealthCare family, located in Illinois and Michigan. OSF HealthCare was founded to continue the healing Ministry of Jesus Christ. "Embracing God’s great gift of life, we are one OSF Ministry transforming health care to improve the lives of those we serve."
- Total investments:
- 40
- Last investment:
- Lead investor:
- 20%
- Fund size:
- $100M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries OSF Ventures invests in
Stages OSF Ventures invests in
Countries OSF Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $4.3M–$22M
- Series B
- $5.5M–$75M
- Series C
- $2M–$50M
Investment Focus
Industry
- Health Care 29 (73%)
- Medical Device 13 (33%)
- Medical 11 (28%)
- Health Diagnostics 7 (18%)
- Artificial Intelligence 6 (15%)
Stage
- Series B 9 (23%)
- Series A 8 (20%)
- Series C 6 (15%)
- Venture - Series Unknown 6 (15%)
- Funding Round 3 (8%)
Country
- United States 30 (75%)
- Israel 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Garrett Vygantas
Managing Director
|
Managing Director | Total investments: 10 | Find email | |
Mayank Taneja
Director, Venture Investments
|
Director, Venture Investments | Total investments: 3 | Find email | |
Michelle Conger
Chief Strategy Officer
|
Chief Strategy Officer | Total investments: 0 | Find email | |
Robert Sehring
Founder & CEO
|
Founder & CEO | Total investments: 1 | Find email | |
Sabina Lepičová
Director, Venture Finance & Administration
|
Director, Venture Finance & Administration | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Icarus Medical Innovations specializes in the design and manufacture of custom knee braces to treat osteoarthritis. | $7.2M / Series A / Jun 17, 2026 | ||
| Apreo Health is developer of medical apparatus designed for diagnosing or treating respiratory, pulmonary, and lung conditions. | Venture - Series Unknown / May 13, 2026 | ||
| Monteris Medical is a medical device venture that develops new technologies for the treatment of cancer. It is a private equity-backed neurosurgical company focused solely on diseases of the brain. It develops MRI-guided, laser-based systems designed for the ablation of brain lesions. The company's system applies focused laser energy to ablatebrain tumors from the inside, with little or no effect on surrounding healthy tissue as well as provides clinicians a new neurosurgical tool that offers real-time control and visualization of the therapy during laser ablation treatment, enabling neurosurgeons to ablate (treat with lethal heat) brain lesions and brain tumors that may be difficult to approach via traditional methods.It was founded in 1999 and has offices in Minneapolis, Minnesota, USA and Winnipeg, Manitoba, Canada. | $28M / Series E / Mar 12, 2026 | ||
| Solaborate is a communication platform company. We believe that reinventing and simplifying communication tools and services represents our greatest opportunity to improve people’s lives and help our planet. Our products empower people to stay connected, improve productivity, and provide better work-life balance.We have a diverse team at officesspread out in the US, China, and Kosovo. As part of our commitment to inclusion and diversity, we cultivate an empathetic workspace, a listening environment, always learning and getting inspired by our community. We grow together and dream about the next thing to create together. | $47M / Venture - Series Unknown / Apr 15, 2025 | ||
| Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology. | Dec 09, 2024 | ||
| Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology. | $50M / Series C / Dec 09, 2024 | ||
| ShiraTronics is in the early stages of developing new innovative therapies to combat debilitating migraine headaches. The company is focused on commercializing novel neuromodulation technologies to treat this large unmet clinical need for patients and physicians. ShiraTronics is the first spinout from NuXcel a global medical device acceleratorcompany. | $66M / Series B / Sep 30, 2024 | ||
| DotCom Therapy specializes in providing speech therapy, occupational therapy, and mental health services via computer, tablet, or smartphone. They hand-match students, patients, and clients with our therapists who provide the highest quality therapy in a live, online, face-to-face setting. It offers speech, occupational and mental health therapy,educational audiology, case management, and literacy services. The company was founded in 2015 and is based in Madison, Wisconsin, United States. | Series C / Apr 10, 2024 | ||
| Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease. | $15.1M / Series A / Dec 08, 2022 | ||
| 410 Medical has developed a simple, intuitive solution that allows a single healthcare provider to rapidly deliver fluid to critically ill patients, improving care, and saving lives. Their device allows fast set-up, improves resuscitation speed, minimizes provider fatigue, and frees providers to address other patient care issues simultaneously.This solution is particularly useful in pre-hospital settings and the emergency department and where speed is critical and resources may be limited.It was founded in 2013 and headquartered in Durham, North Carolina. | $6.3M / Series B / Nov 10, 2022 | ||
| See all 40 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does OSF Ventures invest in?
OSF Ventures invests primarily in Health Care, Medical Device and Medical startups, most often at Series B and Series A stage. Most of the 40 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is OSF Ventures's check size?
OSF Ventures typically joins rounds of $4.3M–$22M at Series A, $5.5M–$75M at Series B and $2M–$50M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds OSF Ventures participates in.
How do I contact OSF Ventures?
Public channels for OSF Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at OSF Ventures?
The team at OSF Ventures includes Garrett Vygantas (Managing Director), Mayank Taneja (Director, Venture Investments) and Michelle Conger (Chief Strategy Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
